DK3681475T3 - Vandige sammensætninger omfattende bilastin og mometason - Google Patents

Vandige sammensætninger omfattende bilastin og mometason Download PDF

Info

Publication number
DK3681475T3
DK3681475T3 DK18786334.5T DK18786334T DK3681475T3 DK 3681475 T3 DK3681475 T3 DK 3681475T3 DK 18786334 T DK18786334 T DK 18786334T DK 3681475 T3 DK3681475 T3 DK 3681475T3
Authority
DK
Denmark
Prior art keywords
bilastine
mometasone
aqueous compositions
compositions
aqueous
Prior art date
Application number
DK18786334.5T
Other languages
English (en)
Inventor
García Tania González
Gorostiza Ana Gonzalo
Herrero Gonzalo Hernández
Poladura Pablo Morán
Arce Arturo Zazpe
Domínguez Neftalí García
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Application granted granted Critical
Publication of DK3681475T3 publication Critical patent/DK3681475T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK18786334.5T 2017-10-16 2018-10-15 Vandige sammensætninger omfattende bilastin og mometason DK3681475T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382686 2017-10-16
PCT/EP2018/078034 WO2019076798A1 (en) 2017-10-16 2018-10-15 AQUEOUS COMPOSITIONS COMPRISING BILASTIN AND MOMETASONE

Publications (1)

Publication Number Publication Date
DK3681475T3 true DK3681475T3 (da) 2021-02-01

Family

ID=60262869

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18786334.5T DK3681475T3 (da) 2017-10-16 2018-10-15 Vandige sammensætninger omfattende bilastin og mometason

Country Status (23)

Country Link
US (1) US11642309B2 (da)
EP (1) EP3681475B1 (da)
JP (1) JP2020536972A (da)
KR (1) KR20200125923A (da)
CN (1) CN111526869A (da)
AU (1) AU2018353360B2 (da)
BR (1) BR112020007569A2 (da)
CA (1) CA3079303A1 (da)
CO (1) CO2020005939A2 (da)
DK (1) DK3681475T3 (da)
EA (1) EA202090965A1 (da)
ES (1) ES2858573T3 (da)
HR (1) HRP20210260T1 (da)
HU (1) HUE053233T2 (da)
IL (1) IL273967A (da)
LT (1) LT3681475T (da)
MA (1) MA50247B1 (da)
MX (1) MX2020003834A (da)
PL (1) PL3681475T3 (da)
PT (1) PT3681475T (da)
SG (1) SG11202003384XA (da)
TW (1) TW201922250A (da)
WO (1) WO2019076798A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201918617D0 (en) * 2019-12-17 2020-01-29 Reckitt Benckiser Health Ltd Personal lubricant composition
CN116211795B (zh) * 2022-12-26 2025-09-26 深圳市贝美药业有限公司 一种比拉斯汀口服液体制剂及其制备方法
WO2025256637A1 (zh) * 2024-06-14 2025-12-18 北京普祺医药科技股份有限公司 一种酪氨酸激酶抑制剂的鼻喷雾剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DE4426709A1 (de) 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
FR2780901B1 (fr) * 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
US20060045850A1 (en) 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
CA2613439A1 (en) 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
WO2007047253A2 (en) 2005-10-11 2007-04-26 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
EP1894559A1 (en) 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation
CN101273993A (zh) * 2007-03-27 2008-10-01 北京亚欣保诚医药科技有限公司 糠酸莫米松溶液型液体制剂
JP2010531898A (ja) * 2007-06-28 2010-09-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド 鼻および眼へのコルチコステロイド水溶液送達
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CN101756998A (zh) * 2008-11-28 2010-06-30 天津金耀集团有限公司 采用环糊精包合糠酸莫米松的鼻用药物组合物
CN201373609Y (zh) 2009-03-13 2009-12-30 潘戈 太阳能集热器箱体
US20110105450A1 (en) 2009-06-05 2011-05-05 Aciex Therapeutics, Inc. Ophthalmic formulations of fluticasone and methods of use
KR101304341B1 (ko) 2011-09-19 2013-09-11 한미약품 주식회사 코르티코스테로이드, 항히스타민제 및 β-사이클로덱스트린을 포함하는, 안정성이 개선된 약학 조성물
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
CN103736098A (zh) * 2013-12-27 2014-04-23 于运红 一种含有比拉斯汀及糠酸莫米松的鼻内给药用药物组合物
CN103784462A (zh) * 2014-02-25 2014-05-14 宋俊智 包含比拉斯汀及甾族化合物的药物制剂
EP3040334A1 (en) * 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
WO2016141219A1 (en) 2015-03-05 2016-09-09 Cosmederm Bioscience, Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
WO2017008265A1 (en) * 2015-07-15 2017-01-19 Abb Technology Ag Conductive bar with annular portion to accommodate test plug
EP3170816A1 (en) * 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds

Also Published As

Publication number Publication date
US11642309B2 (en) 2023-05-09
JP2020536972A (ja) 2020-12-17
KR20200125923A (ko) 2020-11-05
MA50247A (fr) 2020-07-22
MA50247B1 (fr) 2021-02-26
US20210186869A1 (en) 2021-06-24
LT3681475T (lt) 2021-02-25
ES2858573T3 (es) 2021-09-30
HUE053233T2 (hu) 2021-06-28
AU2018353360A1 (en) 2020-05-07
AU2018353360B2 (en) 2021-04-01
EP3681475A1 (en) 2020-07-22
PT3681475T (pt) 2021-03-08
MX2020003834A (es) 2020-08-06
SG11202003384XA (en) 2020-05-28
WO2019076798A1 (en) 2019-04-25
EA202090965A1 (ru) 2020-07-22
PL3681475T3 (pl) 2021-07-05
CN111526869A (zh) 2020-08-11
BR112020007569A2 (pt) 2020-09-24
CA3079303A1 (en) 2019-04-25
HRP20210260T1 (hr) 2021-04-02
EP3681475B1 (en) 2020-12-09
TW201922250A (zh) 2019-06-16
CO2020005939A2 (es) 2020-10-30
IL273967A (en) 2020-05-31

Similar Documents

Publication Publication Date Title
IL293377A (en) Hsd17b13 variants and uses thereof
DK3607069T3 (da) Produkter og sammensætninger
DK3478811T3 (da) Rengøringssammensætninger og anvendelser deraf
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3580561T3 (da) Hla-baserede metoder, sammensætninger og anvendelse heraf
DK3658192T3 (da) Glucocorticoid-receptoragonist og immunokonjugater deraf
DK3443009T3 (da) Anti-tim-3-antistoffer og sammensætninger
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3452463T3 (da) Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf
EP3694918A4 (en) Aqueous binder compositions
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
EP3695040A4 (en) Aqueous binder compositions
DK3494119T3 (da) Forbindelser og sammensætninger og anvendelser deraf
DK3256598T3 (da) Svampestammer og anvendelsesfremgangsmåder
DK3078365T3 (da) Solubiliseringsmidler og vandige sammensætninger omfattende disse
DK3399978T3 (da) Antiproliferative forbindelser og farmaceutiske sammensætninger dermed og anvendelser deraf
DK3423076T3 (da) Topisk cyclosporinholdige formuleringer og anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
IL261777B (en) Palatable compositions including sodium phenylbutyrate and uses thereof
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3522911T3 (da) Sammensætninger omfattende relaxin og fremgangsmåder til anvendelse deraf